AKT1 and bladder transitional cell carcinoma: However, the dysregulation of the PI3K/AKT signaling pathway is reported to be a key factor in the tumorigenesis of BLCA, with approximately 40% of patients with BLCA exhibiting disrupted PI3K/AKT signaling [27].